The most frequently observed treatment-emergent adverse events included hypotension, hypertension, nausea, bradycardia, fever, vomiting, hypoxia, tachycardia and anemia.
The treatment-emergent adverse events in the table as follows were reported in ≤1% of all dexmedetomidine-treated patients that are potentially clinically relevant. (See table.)